Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group
I A Cooper, M M Wolf, T I Robertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
G C Toner, J D Shapiro, C R Laidlaw, et al.
Leukemia & Lymphoma
|
December 29, 2004
A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma
J J Biagi, K E Herbert, C Smith, et al.
Blood
|
March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
J F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
British Journal of Haematology
|
June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
J P Matthews, J F Bishop, G A Young, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group
I A Cooper, M M Wolf, T I Robertson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
G C Toner, J D Shapiro, C R Laidlaw, et al.
Leukemia & Lymphoma
|
December 29, 2004
A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma
J J Biagi, K E Herbert, C Smith, et al.
Blood
|
March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
J F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
British Journal of Haematology
|
June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia
J P Matthews, J F Bishop, G A Young, et al.
Page
of 8